EFTA02655305.pdf

From: jeffrey E. <[email protected]> Sent: Friday, March 24, 2017 1:51 PM To: Subject: Re: decreased by , 1 in 70? for double treat=ent. is it 1-200 for lower ldl. f? On Fri, Mar 24, =017 at 9:48 AM, < > wrote: Strong LDL reduction Data w=th decreased cardiovascular events You saved our dear friend T=L it's really been a great pleasure working with him and you=/div> Good weekend rs Rony Shimony, M.D. F.A.C.C. Assoc=ate Professor of Medicine, Cardiology Icahn School of Medicine a= Mount Sinai Director, Clinical Cardiology <=div> Mount Sinai West Mount Sinai Heart 425 West 59th Street 9th Floor New Yo=k, NY 10019 dictated and sent from an iPhone kindly excuse typos<=div> On Mar 24, 2017, at 7:25 AM, jeffrey E. =R;jeevacation@=mail.com <mailto:[email protected]> wrote: thanks for the article on evolcumab, it is cle=r that it reduces the Id' MARKER. much less clear on its=role in reduction of incidents? you were a mensch with t=rje =C2 please note EFTA_R1_01900333 EFTA02655305  The information co=tained in this communication is confidential, may be attorney-client pr=vileged, may constitute inside information, and is intended only for JEE Unauthorized use= disclosure or copying of this communication or any part thereof is str=ctly prohibited and may be unlawful. If you have received this commu=ication in error, please notify us immediately by return e-mail or by e=mail to [email protected] <mailto:[email protected]> , and destroy this communication and all copies thereo=, including all attachments. copyright -all rights reserved <1=iv> please note Th= information contained in this communication is confidential, may be at=orney-client privileged, may constitute inside information, and is inte=ded only for the use of the addressee. It is the property of JEE =nauthorized use, disclosure or copying of this communication or any par= thereof is strictly prohibited and may be unlawful. If you have receiv=d this communication in error, please notify us immediately by retur= e-mail or by e-mail to [email protected] <mailto:[email protected]> , and destroy this communication and a=I copies thereof, including all attachments. copyright -all rights rese=ved 2 EFTA_R1_01900334 EFTA02655306